Hemolytic-uremic syndrome: Difference between revisions

From IDWiki
()
mNo edit summary
 
Line 2: Line 2:


*Typical HUS is a [[thrombotic microangiopathy]] with prominent renal failure traditionally associated with Shiga toxin-producing [[Escherichia coli]] infection, especially enterohemorrhagic ''E. coli'' O157:H7
*Typical HUS is a [[thrombotic microangiopathy]] with prominent renal failure traditionally associated with Shiga toxin-producing [[Escherichia coli]] infection, especially enterohemorrhagic ''E. coli'' O157:H7
*Difference pathophysiology and treatment from [[atypical hemolytic-uremic syndrome]]
*Different pathophysiology and treatment from [[atypical hemolytic-uremic syndrome]] and [[secondary hemolytic-uremic syndrome]]


===Pathophysiology===
===Pathophysiology===

Latest revision as of 13:29, 20 April 2023

Background

Pathophysiology

  • Typical HUS is caused by Shiga toxin from enterohemorrhagic Escherichia coli (e.g. O157:H7)
  • Shiga toxin is absorbed systemically
    • Damages vascular endothelial cells leading to cytokine release and thrombus formation
    • Actives complement and binds Factor H (a complement regulator)

Risk Factors

  • Younger age
  • Exposure to antibiotics
  • Increased WBC count
  • Vomiting
  • Prolonged diarrhea
  • Presence of stx2a and eae genes

Clinical Manifestations

  • Abdominal pain and watery diarrhea about 4 days after exposure to toxin, progressing to bloody diarrhea with or without vomiting
    • Up to one third do not have bloody diarrhea
    • Fever is mild or absent
  • About 7 days after onset of diarrhea, HUS develops
  • Other preceding infections can include UTI, SSTI, or other causes of gastroenteritis

Management

  • Supportive